Medtech women: Intersect’s lessons for the big boys
This article was originally published in Clinica
Intersect ENT is somewhat unusual in the medtech world: it has a female CEO, Lisa Earnhardt, and more women than men on its senior management team. The company, which counts giant Medtronic among its investors, has developed a steroid-releasing implant, Propel, for the treatment of chronic sinusitis. Clinica spoke to Ms Earnhardt in a recent podcast, and it seems that the gender balance among the company’s top execs is no accident.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.